A See and Treat Paradigm for Cervical Pre-cancer

Stopped early · Not applicable

Conditions studied: Cervical Pre-cancer

In brief

The purpose of this study is to see if the transvaginal colposcope produces similar results to colposcopy for the screening of cervical cancer. In this study the investigators are using an investigational device called the transvaginal colposcope. The word investigational means that the device is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA).

Key facts

Study ID

NCT02477124

Run by

Duke University

People needed

514

Starts

2015-09-01

Expected to finish

2020-03-01

Last updated by the study team

2023-05-18

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing cervicography OR colposcopy OR VIA OR patients undergoing LEEP for the treatment of cervical cancer.
• Age 25 and greater
• Patients of all ethnic backgrounds will be included.
• Ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Children and subjects under 25.

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States
• AIIMS — New Delhi, India
• La Liga Contra el Cancer — Lima, Peru
• Kilimanjaro Christian Medical Centre — Moshi, Tanzania
• University Teaching Hospital — Lusaka, Zambia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.